Total human chorionic gonadotropin is a more suitable diagnostic marker of gestational trophoblastic diseases than the free β-subunit of human chorionic gonadotropin

IF 1.7 Q3 MEDICAL LABORATORY TECHNOLOGY
Hirokazu Usui , Atsuko Mikiya , Eri Katayama , Natsuko Nakamura , Asuka Sato , Hideo Matsui , Makio Shozu , Kaori Koga
{"title":"Total human chorionic gonadotropin is a more suitable diagnostic marker of gestational trophoblastic diseases than the free β-subunit of human chorionic gonadotropin","authors":"Hirokazu Usui ,&nbsp;Atsuko Mikiya ,&nbsp;Eri Katayama ,&nbsp;Natsuko Nakamura ,&nbsp;Asuka Sato ,&nbsp;Hideo Matsui ,&nbsp;Makio Shozu ,&nbsp;Kaori Koga","doi":"10.1016/j.plabm.2023.e00343","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Human chorionic gonadotropin (hCG) levels are essential for the management of trophoblastic diseases. This study aimed to compare the sensitivities and relationships of two hCG measurement methods (total hCG and the free β-subunit of hCG) in managing gestational trophoblastic disease (GTD).</p></div><div><h3><strong>Design and Methods</strong></h3><p>We analyzed data from patients treated for GTD at Chiba University Hospital between 2008 and 2019. We focused on cases where both total hCG (mIU/mL) and the free β-subunit of hCG (ng/mL) were measured on the same day.</p></div><div><h3>Results</h3><p>Out of 80 patients (mean age 38.9 ± 11.7 years) and 158 measurements, 26 had values below the sensitivity threshold for both tests. Fifty-nine measurements were positive for total hCG but below the sensitivity threshold for the free β-subunit of hCG, whereas only two showed the opposite. Seventy-one measurements were positive for both total hCG and the free β-subunit of hCG. There was a significant correlation between total hCG and the free β-subunit of hCG with both positive values, (r = 0.94, p &lt; 0.001; Spearman's correlation test). Of the 85 measurements with undetectable free β-subunit levels, 26 also had undetectable total hCG levels. However, total hCG was detectable in 59 patients from these cases, with a median value (interquartile range) of 2.9 (1.75–4.9) mIU/mL.</p></div><div><h3>Conclusions</h3><p>In the management of GTD, the use of the free β-subunit system alone cannot be recommended.</p></div>","PeriodicalId":20421,"journal":{"name":"Practical Laboratory Medicine","volume":"37 ","pages":"Article e00343"},"PeriodicalIF":1.7000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352551723000379/pdfft?md5=1b6430f9b963924a2f1d8ea6f712b481&pid=1-s2.0-S2352551723000379-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352551723000379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Human chorionic gonadotropin (hCG) levels are essential for the management of trophoblastic diseases. This study aimed to compare the sensitivities and relationships of two hCG measurement methods (total hCG and the free β-subunit of hCG) in managing gestational trophoblastic disease (GTD).

Design and Methods

We analyzed data from patients treated for GTD at Chiba University Hospital between 2008 and 2019. We focused on cases where both total hCG (mIU/mL) and the free β-subunit of hCG (ng/mL) were measured on the same day.

Results

Out of 80 patients (mean age 38.9 ± 11.7 years) and 158 measurements, 26 had values below the sensitivity threshold for both tests. Fifty-nine measurements were positive for total hCG but below the sensitivity threshold for the free β-subunit of hCG, whereas only two showed the opposite. Seventy-one measurements were positive for both total hCG and the free β-subunit of hCG. There was a significant correlation between total hCG and the free β-subunit of hCG with both positive values, (r = 0.94, p < 0.001; Spearman's correlation test). Of the 85 measurements with undetectable free β-subunit levels, 26 also had undetectable total hCG levels. However, total hCG was detectable in 59 patients from these cases, with a median value (interquartile range) of 2.9 (1.75–4.9) mIU/mL.

Conclusions

In the management of GTD, the use of the free β-subunit system alone cannot be recommended.

总人绒毛膜促性腺激素比游离人绒毛膜促性腺激素β-亚基更适合作为妊娠滋养细胞疾病的诊断指标
目的人绒毛膜促性腺激素(hCG)水平对滋养细胞疾病的治疗至关重要。本研究旨在比较两种hCG测量方法(总hCG和hCG游离β-亚基)在妊娠滋养细胞疾病(GTD)诊断中的敏感性和相关性。设计与方法我们分析了2008年至2019年在千叶大学医院接受GTD治疗的患者的数据。我们关注的是同一天测量总hCG (mIU/mL)和hCG游离β-亚单位(ng/mL)的病例。结果80例患者(平均年龄38.9±11.7岁)158次检测中,26例两项检测均低于敏感阈值。59项测量显示总hCG阳性,但低于hCG自由β亚基的敏感阈值,而只有2项显示相反。71例hCG总量和游离β- hCG亚基均呈阳性。总hCG与hCG游离β-亚基均呈阳性,相关性显著(r = 0.94, p <0.001;Spearman相关检验)。在85个检测不到游离β亚基水平的测量中,26个也检测不到总hCG水平。然而,这些病例中有59例患者可检测到总hCG,中位数(四分位数范围)为2.9 (1.75-4.9)mIU/mL。结论在GTD的治疗中,不建议单独使用游离β-亚基系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Practical Laboratory Medicine
Practical Laboratory Medicine Health Professions-Radiological and Ultrasound Technology
CiteScore
3.50
自引率
0.00%
发文量
40
审稿时长
7 weeks
期刊介绍: Practical Laboratory Medicine is a high-quality, peer-reviewed, international open-access journal publishing original research, new methods and critical evaluations, case reports and short papers in the fields of clinical chemistry and laboratory medicine. The objective of the journal is to provide practical information of immediate relevance to workers in clinical laboratories. The primary scope of the journal covers clinical chemistry, hematology, molecular biology and genetics relevant to laboratory medicine, microbiology, immunology, therapeutic drug monitoring and toxicology, laboratory management and informatics. We welcome papers which describe critical evaluations of biomarkers and their role in the diagnosis and treatment of clinically significant disease, validation of commercial and in-house IVD methods, method comparisons, interference reports, the development of new reagents and reference materials, reference range studies and regulatory compliance reports. Manuscripts describing the development of new methods applicable to laboratory medicine (including point-of-care testing) are particularly encouraged, even if preliminary or small scale.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信